Clinical trials of new drugs for Alzheimer disease
LK Huang, SP Chao, CJ Hu - Journal of biomedical science, 2020 - Springer
Alzheimer disease (AD) accounts for 60–70% of dementia cases. Given the seriousness of
the disease and continual increase in patient numbers, developing effective therapies to …
the disease and continual increase in patient numbers, developing effective therapies to …
Role of tau protein in Alzheimer's disease: The prime pathological player
Alzheimer's disease (AD) is a prevalently found tauopathy characterized by memory loss
and cognitive insufficiency. AD is an age-related neurodegenerative disease with two major …
and cognitive insufficiency. AD is an age-related neurodegenerative disease with two major …
The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer's disease
Alzheimer's disease (AD) is a chronic disabling disease that affects the central nervous
system. The main consequences of AD include the decline of cognitive functions and …
system. The main consequences of AD include the decline of cognitive functions and …
Effects of in vivo conditions on amyloid aggregation
One of the grand challenges of biophysical chemistry is to understand the principles that
govern protein misfolding and aggregation, which is a highly complex process that is …
govern protein misfolding and aggregation, which is a highly complex process that is …
S100 proteins in Alzheimer's disease
JS Cristóvão, CM Gomes - Frontiers in Neuroscience, 2019 - frontiersin.org
S100 proteins are calcium-binding proteins that regulate several processes associated with
Alzheimer's disease (AD) but whose contribution and direct involvement in disease …
Alzheimer's disease (AD) but whose contribution and direct involvement in disease …
[HTML][HTML] A review for the pharmacological effect of lycopene in central nervous system disorders
D Chen, C Huang, Z Chen - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Lycopene is an aliphatic hydrocarbon carotenoid extracted from plants like tomatoes,
papayas, and watermelons. Previous studies have shown that lycopene can exert …
papayas, and watermelons. Previous studies have shown that lycopene can exert …
The many faces of astrocytes in Alzheimer's disease
Alzheimer's disease (AD) is a progressive neurodegenerative disease and is the most
common cause of dementia in an aging population. The majority of research effort has …
common cause of dementia in an aging population. The majority of research effort has …
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges
Increasing life expectancy has led to an aging population, which has consequently
increased the prevalence of dementia. Alzheimer's disease (AD), the most common form of …
increased the prevalence of dementia. Alzheimer's disease (AD), the most common form of …
PROTACs to address the challenges facing small molecule inhibitors
P Martín-Acosta, X Xiao - European journal of medicinal chemistry, 2021 - Elsevier
Small molecule inhibitors of proteins represent important medicines and critical chemical
tools to investigate the biology of the target proteins. Advances in various-omics …
tools to investigate the biology of the target proteins. Advances in various-omics …
Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer's disease
SA Farr, E Roesler, ML Niehoff… - Journal of …, 2019 - content.iospress.com
Metformin is used for the treatment of insulin resistant diabetes. Diabetics are at an
increased risk of developing dementia. Recent epidemiological studies suggest that …
increased risk of developing dementia. Recent epidemiological studies suggest that …